Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV000681623 | SCV000809064 | uncertain significance | not provided | 2018-03-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000681623 | SCV004157887 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | GEMIN5: BP4, BS2 |
Breakthrough Genomics, |
RCV000681623 | SCV005188708 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Gene |
RCV000681623 | SCV005379955 | likely pathogenic | not provided | 2024-04-12 | criteria provided, single submitter | clinical testing | Published functional studies demonstrated reduced dimerization and ribosome association compared to wildtype (PMID: 35393353); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35295849, 35393353, 36980979, 16677673, 38316953) |